Omega-6:Omega-3 Ratio
Omega-6:Omega-3 Ratio is a number a lab report prints. What it measures, in the Library's words: The balance of anti-inflammatory omega-3s versus more inflammation-associated omega-6 derivatives making up cell membranes. No single unit is recorded for it on its own; the range note on this page prints the units its entry uses. It is read on the Adolescence, Alzheimer's and Dementia, Cognitive and Focus, Neuro and Stress, Mood and Recovery panels.
What it measures
The balance of anti-inflammatory omega-3s versus more inflammation-associated omega-6 derivatives making up cell membranes.
Also printed on lab reports as: omega 6 omega 3 ratio; omega 6 3 ratio; omega 6 to omega 3 ratio; aa epa ratio; arachidonic acid epa ratio.
Filed under: Vitamins, Minerals & Nutrients.
Range and unit
No single unit is recorded for this marker on its own. The range note below prints the units its entry uses, and your report's own unit comes first.
How the entry records the range: No universal clinical range; the "Omega-3 Index" (EPA+DHA as % of red blood cell fatty acids) research uses above 8% as a cardioprotective target and under 4% as high-risk, though Function's assay methodology may differ. Omega-6/Omega-3 ratio: functional-medicine opinion often targets under 4:1, versus a typical modern Western-diet ratio of 15:1-20:1 -- this ratio target itself is debated in the literature.
A range is a reference with a history, never a verdict. Measurement science, not a diagnosis. Your clinician has the last word.
Where it is read
The Library reads Omega-6:Omega-3 Ratio on these panels.
- Adolescence panel
- Alzheimer's and Dementia panel
- Cognitive and Focus panel
- Neuro panel
- Stress, Mood and Recovery panel
Open Omega-6:Omega-3 Ratio in the Library, with the studies underneath
The pairs it enters
Some numbers say more read together than apart. These are the pairs the Library lists for this marker.
Omega-6:Omega-3 Ratio enters it, read with EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid).
Omega-6:Omega-3 Ratio is read from Arachidonic Acid, Linoleic Acid, EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid).
What moves it
A lab number moves with its cofactors, not on its own. These are shown as a set, in alphabetical order; a count is how much has been read, never how strong. Each study id opens the paper the Library records.
Read alongside it
- Calcium · named together in 106 studiesHH-46674HH-50967HH-54234
- Choline · named together in 57 studiesHH-4156HH-47663HH-69319
- Folate (vitamin B9) · named together in 130 studiesHH-41322HH-45640HH-45686
- Iodine · named together in 78 studiesHH-38299HH-38318HH-46889
- Iron · named together in 138 studiesHH-14492HH-25534HH-33464
- Magnesium · named together in 89 studiesHH-3979HH-1336HH-45918
- Omega-3 fats (EPA, DHA) · named together in 11,176 studiesHH-0001HH-0018HH-0026
- Selenium · named together in 205 studiesHH-2891HH-37864HH-37875
- Vitamin B12 · named together in 121 studiesHH-45640HH-46140HH-54379
- Vitamin C · named together in 64 studiesHH-4219HH-4224HH-13899
- Vitamin D · named together in 517 studiesHH-1336HH-3145HH-3169
- Vitamin E · named together in 427 studiesHH-0547HH-0814HH-3979
- Zinc · named together in 171 studiesHH-1448HH-4162HH-41222
Competes with it, draws it down, or moves it down
- Omega-3 fats (EPA, DHA) · lowers it (1)HH-175547
Tests a routine panel leaves out
For some of these nutrients the map names a test that a routine blood count, metabolic panel, lipid panel and TSH do not carry: Folate, Urinary iodine, Ferritin and iron studies, Magnesium (red-cell), Omega-3 Index, Selenium, Vitamin B12, Plasma vitamin C, Vitamin D (25-hydroxy), Vitamin E (alpha-tocopherol) and Zinc. How to get measured lists where each can be ordered.
The 37 studies behind these rows
- HH-0001Final Risk Evaluation for 1,4-Dioxane (2020)
- HH-0018Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants (1997)
- HH-0026Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial (2013)
- HH-0547Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial (1999)
- HH-0814Fish oil, vitamin E and lipid peroxidation, RCT (1997)
- HH-1336Nutraceuticals in Diabetes and Metabolic Syndrome (2010)
- HH-13899Acetylcholinesterase Inhibition and Antioxidant Activity of DHA-Disubstituted Phospholipids. (2025)
- HH-1448Mercury Exposure, Nutritional Deficiencies and Metabolic Disruptions May Affect Learning in Children (2009)
- HH-14492ω-6 PUFA-enriched membrane phospholipid composition of cardiomyocytes increases the susceptibility to iron-induced ferroptosis and inflammation. (2025)
- HH-175547Docosahexaenoic acid supplementation in lactating women increases breast milk and plasma docosahexaenoic acid concentrations and alters infant omega 6:3 fatty acid ratio (2015)
- HH-25534The concentration of potentially toxic elements (PTEs) in drinking water from Shiraz, Iran: a health risk assessment of samples (2023)
- HH-2891Urologist blames Big Pharma as concerns mount over his research, (2023)
- HH-3145Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial (2022)
- HH-3169Vitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double-Blind, Placebo-Controlled Trial (2024)
- HH-33464Fish Oil Ameliorates Deoxynivalenol-Induced Liver Injury Through Modulating Ferroptosis Signaling Pathway in Weaned Pigs (2026)
- HH-37864Mercury toxicity and neurodegenerative effects (2014)
- HH-37875Ferroptosis in schizophrenia: Mechanisms and therapeutic potentials (Review) (2025)
- HH-38299Seafood: nutritional benefits and risk aspects (2012)
- HH-38318Nutrition and neurodevelopment: the search for candidate nutrients in the Seychelles Child Development Nutrition Study (2020)
- HH-3979A meta-analysis of effects of vitamin E supplementation alone and in combination with omega-3 or magnesium on polycystic ovary syndrome. (2022)
- HH-41222Nutritional Genomics: Implications for Age-Related Macular Degeneration (2024)
- HH-41322Use of a Micronutrient Cocktail to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Adults with Obesity: A Randomized, Double-Blinded Pilot Clinical Trial (2024)
- HH-4156Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature. (2021)
- HH-4162Fishy business: effect of omega-3 fatty acids on zinc transporters and free zinc availability in human neuronal cells. (2014)
- HH-4219Activated astrocytes increase dehydroascorbic acid uptake, changing intracellular metabolism and vitamin C recycling and emulating neuropathological conditions. (2026)
- HH-4224Redox Properties of Human Erythrocytes Are Adapted for Vitamin C Recycling. (2021)
- HH-45640Nutrient and genetic biomarkers of nutraceutical treatment response in mood and psychotic disorders: a systematic review (2021)
- HH-45686Lifestyle and stroke risk: a review (2009)
- HH-45918Dietetic Prescriptions in Bipolar Disorder: Nutritional Strategies to Support Mood Stability and Reduce Relapse Risk-A Narrative Review (2026)
- HH-46140Unveiling the mechanistic nexus: how micronutrient enrichment shapes brain function, and cognitive health (2025)
- HH-46674Premenstrual Syndrome and Nutritional Factors: A Narrative Review of Current Evidence and Clinical Implications (2026)
- HH-46889Maternal nutrition and its effects on fetal neurodevelopment (2024)
- HH-47663Selected Lipidome Components and Their Association with Perinatal Depression (2025)
- HH-50967Gynecology: select topics (2002)
- HH-54234Effect of omega-3 fatty acids, docosahexaenoic and eicosapentaenoic, on norepinephrine-induced contractions (1992)
- HH-54379Homocysteine lowering with folate, vitamin B12 and vitamin B6 does not alter the proportion of n‐3 long chain polyunsaturated fatty acids (LCPUFA) in plasma phosphatidylcholine (2008)
- HH-69319Over the Counter Supplements for Memory: A Review of Available Evidence (2023)
Studies that name it
86 approved studies in the library name Omega-6:Omega-3 Ratio. 3 of them are recorded as a trial, an observational study or a pooled analysis; most rows record no design.
The 8 below are listed in this order: studies that name it in the title, then recorded trials, observational studies and pooled analyses, then the newest.
- Omega-3 fatty-acids modulate symptoms of depressive disorder, serum levels of omega-3 fatty acids and omega-6/omega-3 ratio in children. A randomized, double-blind and controlled trial. (2020) · HH-436211 · trial, observational study or pooled analysis
- Lower Omega-6–Omega-3 Ratio Increased Milk Production and Had Limited Effects on Early Pregnancy Development in Dairy Cattle (2026) · HH-236170
- Higher Total Omega-3 PUFA Levels and a Lower Omega-6:Omega-3 Ratio Are Associated with Lower Temporal Lobe Volume in Alzheimer's Disease. (2026) · HH-646574
- Insight into the effects of Omega-3 fatty acids on gut microbiota: impact of a balanced tissue Omega-6/Omega-3 ratio (2025) · HH-136330
- Association of omega-3, omega-6 fatty acids intakes and omega-6: omega-3 ratio with the prevalence of suicidal ideation: mediating role of C-reactive protein (2025) · HH-293796
- Omega-6/Omega-3 Ratio as a Protective Factor in Lung Cancer: A Mendelian Randomization Study on Polyunsaturated Fatty Acids and Lung Adenocarcinoma Risk (2025) · HH-537504
- Effects of low omega-6/omega-3 ratio and high omega-9/omega-6 ratio oil blend on inflammation and oxidative stress after tooth extraction in rats (2025) · HH-807537
- Omega‐6/Omega‐3 Ratio in Dementia Prevention ‐ Study Design and preliminary data of a feasibility study on lifestyle intervention (2024) · HH-275334
Counted on 2026-11-22 across 923,626 approved studies: a study is counted when its title or its one-line takeaway names the marker. A count is where the library has been pointed, never a verdict on the field. Open Omega-6:Omega-3 Ratio in the Library
Concerns that name it
A concern is a question, not a diagnosis. These concern pages either list this marker among the numbers the Library ties to them, or send you to a panel that reads it.
Enter your numbers
Type in the value from a report you already have, or import the report, and each one is read against the evidence. Your lab values stay on your device. They are never uploaded to The Lab Atlas.
All markers · Questions people ask · Questions: info@thelabatlas.org